Sectors
AMRX
Amneal Pharmaceuticals, Inc.
17.91
2 x 17.83
2 x 17.90
bid
ask
+
0.03
0.17%
09:39 AM
timesize
| Ytd | 42.14% | |
| 1y | 102.60% |
17.77
day range
17.94
8.82
52 week range
19.26
| Open | 17.83 | Prev Close | 17.88 | Low | 17.77 | High | 17.94 | Mkt Cap | 5.72B |
| Vol | 37.41K | Avg Vol | 1.96M | EPS | 0.90 | P/E | 19.90 | Forward P/E | 15.34 |
| Beta | 1.27 | Short Ratio | 3.55 | Inst. Own | 53.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 16.74 | 200-d Avg | 13.73 | 1yr Est | 20.75 |
| Income Statement | |||
| Total Revenue | 796.20M | ||
| Revenues (USD) | 796.20M | ||
| Cost of Revenue | 461.69M | ||
| Gross Profit | 334.51M | ||
| Operating Expenses | 204.74M | ||
| Research and Development Expense | 39.02M | ||
| Selling, General and Administrative Expense | 148.72M | ||
| Operating Income | 129.77M | ||
| Interest Expense | 55.04M | ||
| Income Tax Expense | 1.38M | ||
| Net Income | 57.66M | ||
| Net Income Common Stock | 57.66M | ||
| Net Income Common Stock (USD) | 57.66M | ||
| Consolidated Income | 69.61M | ||
| Net Income to Non-Controlling Interests | 11.95M | ||
| Earnings per Basic Share | 0.18 | ||
| Earnings per Basic Share (USD) | 0.18 | ||
| Earnings per Diluted Share | 0.18 | ||
| Earning Before Interest & Taxes (EBIT) | 114.08M | ||
| Earning Before Interest & Taxes (USD) | 114.08M | ||
| Weighted Average Shares | 319.20M | ||
| Weighted Average Shares Diluted | 328.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 136.28M | ||
| Cash and Equivalents (USD) | 136.28M | ||
| Trade and Non-Trade Receivables | 1.02B | ||
| Current Assets | 1.95B | ||
| Property, Plant & Equipment Net | 567.32M | ||
| Total Assets | 3.78B | ||
| Debt Current | 121.42M | ||
| Total Debt | 2.79B | ||
| Current Liabilities | 883.19M | ||
| Debt Non-Current | 2.67B | ||
| Total Liabilities | 3.74B | ||
| Accumulated Retained Earnings (Deficit) | -415.09M | ||
| Accumulated Other Comprehensive Income | -100.67M | ||
| Shareholders Equity | 33.02M | ||
| Shareholders Equity (USD) | 33.02M | ||
| Assets Non-Current | 1.83B | ||
| Total Debt (USD) | 2.79B | ||
| Goodwill and Intangible Assets | 1.18B | ||
| Inventory | 677.95M | ||
| Liabilities Non-Current | 2.86B | ||
| Trade and Non-Trade Payables | 724.10M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 47.80M | ||
| Net Cash Flow from Financing | 79.36M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -64.79M | ||
| Capital Expenditure | -45.59M | ||
| Issuance (Purchase) of Equity Shares | 42.00K | ||
| Issuance (Repayment) of Debt Securities | 93.82M | ||
| Net Cash Flow from Investing | -122.74M | ||
| Net Cash Flow from Operations | -21.24M | ||
| Effect of Exchange Rate Changes on Cash | -164.00K | ||
| Share Based Compensation | 10.39M | ||